Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Saroja Pharma Industries India Ltd

SAROJA·NSE

₹40.900.00%Wed, 23 Sept '26

Industry:Chemicals - Speciality

Indices:

Saroja Pharma Industries India Ltd

SAROJA

NSE

₹40.90

0.00%

|Wed, 23 Sept '26

SOICxStockScans Reports

Industry

Chemicals - Speciality

Indices

View

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Quick Ratios

Edit Ratios

Mkt Cap

Market Capitalization

₹16Cr

Close Price

₹40.90

Industry

Chemicals - Speciality

Price To Earnings

10.17

Price To Sales

0.23

Revenue

₹70Cr

Rev Gr TTM

Revenue Growth TTM

30.55%

PAT Gr TTM

PAT Growth TTM

55.23%

Quarterly Results

Standalone

Numbers

Percentage

Quarter	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue RevenueCr	27	24	21	20	19	35	38	32
Growth YoY Revenue Growth YoY%			-20.4	-17.3	-11.4	79.0	104.9	-9.2
Expenses ExpensesCr	25	22	20	18	18	33	37	29
Operating Profit Operating ProfitCr	1	1	1	1	1	2	1	3
OPM OPM%	5.1	5.8	5.5	7.1	6.0	4.7	2.5	8.6
Other Income Other IncomeCr	0	0	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	1	1	1	1	1	1	1	1
Depreciation DepreciationCr	0	0	0	0	0	0	0	0
PBT PBTCr	1	1	1	1	1	1	1	2
Tax TaxCr	0	0	0	0	0	0	0	0
PAT PATCr	1	1	1	0	0	1	1	1
Growth YoY PAT Growth YoY%			-9.1	-29.6	-32.0	84.2	67.7	48.6
NPM NPM%	2.1	2.3	2.4	1.9	1.8	2.0	1.5	3.3
EPS EPS₹	0.0	0.0	1.7	2.5	0.8	1.7	1.4	2.6

Quarter	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue RevenueCr	27	24	21	20	19	35	38	32
Growth YoY Revenue Growth YoY%			-20.4	-17.3	-11.4	79.0	104.9	-9.2
Expenses ExpensesCr	25	22	20	18	18	33	37	29
Operating Profit Operating ProfitCr	1	1	1	1	1	2	1	3
OPM OPM%	5.1	5.8	5.5	7.1	6.0	4.7	2.5	8.6
Other Income Other IncomeCr	0	0	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	1	1	1	1	1	1	1	1
Depreciation DepreciationCr	0	0	0	0	0	0	0	0
PBT PBTCr	1	1	1	1	1	1	1	2
Tax TaxCr	0	0	0	0	0	0	0	0
PAT PATCr	1	1	1	0	0	1	1	1
Growth YoY PAT Growth YoY%			-9.1	-29.6	-32.0	84.2	67.7	48.6
NPM NPM%	2.1	2.3	2.4	1.9	1.8	2.0	1.5	3.3
EPS EPS₹	0.0	0.0	1.7	2.5	0.8	1.7	1.4	2.6

Profit & Loss

Standalone

Numbers

Percentage

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	37	56	50	41	54	70
Growth Revenue Growth%		51.8	-9.8	-19.0	32.1	30.5
Expenses ExpensesCr	35	54	47	38	51	66
Operating Profit Operating ProfitCr	1	2	3	3	3	4
OPM OPM%	3.5	3.8	5.4	6.3	5.2	5.3
Other Income Other IncomeCr	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	1	1	1	1	1
Depreciation DepreciationCr	0	0	0	0	0	0
PBT PBTCr	1	2	1	1	1	2
Tax TaxCr	0	0	0	0	0	1
PAT PATCr	1	1	1	1	1	2
Growth PAT Growth%		55.9	-7.0	-17.2	17.8	56.1
NPM NPM%	2.0	2.0	2.1	2.2	1.9	2.3
EPS EPS₹	2.7	4.0	3.6	2.5	2.6	4.0

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	37	56	50	41	54	70
Growth Revenue Growth%		51.8	-9.8	-19.0	32.1	30.5
Expenses ExpensesCr	35	54	47	38	51	66
Operating Profit Operating ProfitCr	1	2	3	3	3	4
OPM OPM%	3.5	3.8	5.4	6.3	5.2	5.3
Other Income Other IncomeCr	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	1	1	1	1	1
Depreciation DepreciationCr	0	0	0	0	0	0
PBT PBTCr	1	2	1	1	1	2
Tax TaxCr	0	0	0	0	0	1
PAT PATCr	1	1	1	1	1	2
Growth PAT Growth%		55.9	-7.0	-17.2	17.8	56.1
NPM NPM%	2.0	2.0	2.1	2.2	1.9	2.3
EPS EPS₹	2.7	4.0	3.6	2.5	2.6	4.0

Balance Sheet

Standalone

Numbers

Percentage

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	0	0	3	4	4	4
Reserves ReservesCr	1	4	2	11	12	13
Current Liabilities Current LiabilitiesCr	6	10	13	9	22	17
Non Current Liabilities Non Current LiabilitiesCr	1	2	3	3	1	7
Total Liabilities Total LiabilitiesCr	8	16	21	27	40	42
Current Assets Current AssetsCr	8	15	16	18	27	19
Non Current Assets Non Current AssetsCr	0	0	5	9	12	23
Total Assets Total AssetsCr	8	16	21	27	40	42

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	0	0	3	4	4	4
Reserves ReservesCr	1	4	2	11	12	13
Current Liabilities Current LiabilitiesCr	6	10	13	9	22	17
Non Current Liabilities Non Current LiabilitiesCr	1	2	3	3	1	7
Total Liabilities Total LiabilitiesCr	8	16	21	27	40	42
Current Assets Current AssetsCr	8	15	16	18	27	19
Non Current Assets Non Current AssetsCr	0	0	5	9	12	23
Total Assets Total AssetsCr	8	16	21	27	40	42

Cash Flow

Standalone

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-1	-4	2	1	1	7
Investing Cash Flow Investing Cash FlowCr	0	0	-5	-5	-3	-12
Financing Cash Flow Financing Cash FlowCr	1	4	3	4	2	4
Net Cash Flow Net Cash FlowCr	0	0	0	0	0	0
Free Cash Flow Free Cash FlowCr	-1	-4	-2	1	1	8
CFO To PAT CFO To PAT%	-143.1	-322.3	206.8	116.7	111.0	460.9
CFO To EBITDA CFO To EBITDA%	-80.3	-174.8	80.6	40.1	41.2	201.5

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-1	-4	2	1	1	7
Investing Cash Flow Investing Cash FlowCr	0	0	-5	-5	-3	-12
Financing Cash Flow Financing Cash FlowCr	1	4	3	4	2	4
Net Cash Flow Net Cash FlowCr	0	0	0	0	0	0
Free Cash Flow Free Cash FlowCr	-1	-4	-2	1	1	8
CFO To PAT CFO To PAT%	-143.1	-322.3	206.8	116.7	111.0	460.9
CFO To EBITDA CFO To EBITDA%	-80.3	-174.8	80.6	40.1	41.2	201.5

Ratios

Standalone

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				14	15	11	16
Price To Earnings Price To Earnings				16.1	14.7	7.0	10.2
Price To Sales Price To Sales				0.3	0.3	0.2	0.2
Price To Book Price To Book				1.0	1.0	0.7	0.9
EV To EBITDA EV To EBITDA				7.6	8.7	6.9	8.3
Profitability Ratios Profitability Ratios
GPM GPM%	9.1	9.5	9.6	12.2	9.5	8.9	8.9
OPM OPM%	3.5	3.8	5.4	6.3	5.2	5.3	5.3
NPM NPM%	2.0	2.0	2.1	2.2	1.9	2.3	2.3
ROCE ROCE%	34.5	23.4	18.4	13.0	11.4	11.6	11.6
ROE ROE%	78.1	28.3	20.9	6.0	6.6	9.3	9.3
ROA ROA%	8.9	7.3	5.0	3.3	2.6	3.9	3.9
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				14	15	11	16
Price To Earnings Price To Earnings				16.1	14.7	7.0	10.2
Price To Sales Price To Sales				0.3	0.3	0.2	0.2
Price To Book Price To Book				1.0	1.0	0.7	0.9
EV To EBITDA EV To EBITDA				7.6	8.7	6.9	8.3
Profitability Ratios Profitability Ratios
GPM GPM%	9.1	9.5	9.6	12.2	9.5	8.9	8.9
OPM OPM%	3.5	3.8	5.4	6.3	5.2	5.3	5.3
NPM NPM%	2.0	2.0	2.1	2.2	1.9	2.3	2.3
ROCE ROCE%	34.5	23.4	18.4	13.0	11.4	11.6	11.6
ROE ROE%	78.1	28.3	20.9	6.0	6.6	9.3	9.3
ROA ROA%	8.9	7.3	5.0	3.3	2.6	3.9	3.9
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Documents — Saroja Pharma Industries India Ltd

Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/6knzqbapm71v89mu0nvumop1.pdf
Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/eo2iys8d8x49i524s5u29b1c.pdf
Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/gmq69bwd3clq2h9r9piowze9.pdf
Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/2em2429fcgbh3hbn284ygd38.pdf
FY2025 Annual Report (PDF): https://www.stockscans.in/document/pdo85vjcbk30r811okhpppm5.pdf
FY2024 Annual Report (PDF): https://www.stockscans.in/document/mmwdp6mjumfdahq51yj2a6r7.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in

349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies